LeadIQ logo
Learn more at LeadIQ.com
Sermonix Pharmaceuticals

Sermonix Pharmaceuticals Employee Directory

Pharmaceutical ManufacturingOhio, United States11-50 Employees

Sermonix Pharmaceuticals, founded by David Portman, MD, a leading clinical researcher and expert in women’s health, menopause, and selective estrogen receptor modulators (SERMs), focuses on developing innovative therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers.

Our ELAINE-2 study is evaluating investigational lasofoxifene in combination with the CDK4/6 inhibitor abemaciclib for the treatment of metastatic breast cancer with an ESR1 mutation. Lasofoxifene’s bioavailability and activity in mutations of the estrogen receptor could potentially hold promise for patients who have acquired endocrine resistance due to ESR1 mutations, a common finding in the metastatic setting and an area of high unmet medical need.

Lasofoxifene, the only SERM currently being developed exclusively to treat breast cancers with ESR1 mutations, could, if approved, play a critical role in the targeted precision medicine treatment of advanced ER+ breast cancer.

Lasofoxifene’s novel activity in ESR1 mutations was discovered at Duke University, and Sermonix has exclusive rights to develop and commercialize lasofoxifene in this area.

Find Sermonix Pharmaceuticals employees' phone numbers or email addresses

Sermonix Pharmaceuticals Global Highlights

Location
Employees

North America
10

Minus sign iconPlus sign icon
  • United States Of America
    10

Europe
1

Minus sign iconPlus sign icon
  • Switzerland
    1

Sermonix Pharmaceuticals's Leadership

Sermonix Pharmaceuticals Employee Metrics

100%
50%
0%
2024
2023
  • Operations
  • Analytics
  • Consultant
  • Pharmaceuticals
  • Product Management
  • Other

Contact profiles from Sermonix Pharmaceuticals

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Sermonix Pharmaceuticals known for?

Minus sign iconPlus sign icon
Sermonix Pharmaceuticals was founded in 2014 operates in the Pharmaceutical Manufacturing industry. The company's main headquarters is located in 250 E Broad St Suite 250 Columbus, Ohio 43215 US. Explore Sermonix Pharmaceuticals's company overview page for more information.

What is Sermonix Pharmaceuticals's most common email format?

Minus sign iconPlus sign icon
Sermonix Pharmaceuticals employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Sermonix Pharmaceuticals email formats with LeadIQ.

How many employees does Sermonix Pharmaceuticals have currently?

Minus sign iconPlus sign icon
Sermonix Pharmaceuticals has approximately 11 employees as of November 2022. These team members are located across 2 continents, including North AmericaEurope.

Who are Sermonix Pharmaceuticals's key employees and leadership?

Minus sign iconPlus sign icon

As of November 2022, Sermonix Pharmaceuticals's key employees include:

  • Chief Operating Officer: M. P.
  • Executive Assistant To Ceo & Coo: S. D.
  • Controller At Sermonix Pharmaceuticals, Inc: J. G.
  • Clinical Project Manager: G. G. B.
  • Product Manager: M. K.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.